CBIH Revenue

Cannabis Bioscience International Holdings had revenue of $11.21K in the quarter ending February 28, 2026, a decrease of -24.95%. This brings the company's revenue in the last twelve months to $123.63K, down -64.05% year-over-year. In the fiscal year ending May 31, 2025, Cannabis Bioscience International Holdings had annual revenue of $303.02K with 21.77% growth.

Revenue (ttm)

123.63K

Revenue Growth

-64.05%

P/S Ratio

28.46

Revenue / Employee

61.81K

Employees

Market Cap

3.52M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2025	303.02K	54.18K	21.77%
May 31, 2024	248.84K	-67.98K	-21.46%
May 31, 2023	316.83K	101.85K	47.37%
May 31, 2022	214.98K	-546.76K	-71.78%
May 31, 2021	761.74K	471.50K	162.46%
May 31, 2020	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Trees	14.50M
Rafarma Pharmaceuticals	133.33K
Eagle Pharmaceuticals	257.55M
Indo Global Exchange(s) PTE	3.49K
SOHM, Inc.	1.30M
Tristar Wellness Solutions	4.00M

Revenue Rankings

Cannabis Bioscience International Holdings News

3 months ago - CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence - Newsfile Corp
4 months ago - CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accelerate Medical Cannabis Research in the Schedule III Transition - Newsfile Corp
4 months ago - CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways - Newsfile Corp
4 months ago - CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities - Newsfile Corp
7 months ago - CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery - Newsfile Corp
7 months ago - CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center - Newsfile Corp
1 year ago - CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy - Newsfile Corp
1 year ago - CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings - Newsfile Corp

More News